PPAR-α and glucocorticoid receptor synergize to promote erythroid progenitor self-renewal

Hsiang Ying Lee, Xiaofei Gao, M. Inmaculada Barrasa, Hu Li, Russell R. Elmes, Luanne L. Peters, Harvey F. Lodish

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Many acute and chronic anaemias, including haemolysis, sepsis and genetic bone marrow failure diseases such as Diamond-Blackfan anaemia, are not treatable with erythropoietin (Epo), because the colony-forming unit erythroid progenitors (CFU-Es) that respond to Epo are either too few in number or are not sensitive enough to Epo to maintain sufficient red blood cell production. Treatment of these anaemias requires a drug that acts at an earlier stage of red cell formation and enhances the formation of Epo-sensitive CFU-E progenitors. Recently, we showed that glucocorticoids specifically stimulate self-renewal of an early erythroid progenitor, burst-forming unit erythroid (BFU-E), and increase the production of terminally differentiated erythroid cells. Here we show that activation of the peroxisome proliferator-activated receptor α (PPAR-α) by the PPAR-α agonists GW7647 and fenofibrate synergizes with the glucocorticoid receptor (GR) to promote BFU-E self-renewal. Over time these agonists greatly increase production of mature red blood cells in cultures of both mouse fetal liver BFU-Es and mobilized human adult CD34 + peripheral blood progenitors, with a new and effective culture system being used for the human cells that generates normal enucleated reticulocytes. Although Ppara-/- mice show no haematological difference from wild-type mice in both normal and phenylhydrazine (PHZ)-induced stress erythropoiesis, PPAR-α agonists facilitate recovery of wild-type but not Ppara-/- mice from PHZ-induced acute haemolytic anaemia. We also show that PPAR-α alleviates anaemia in a mouse model of chronic anaemia. Finally, both in control and corticosteroid-treated BFU-E cells, PPAR-α co-occupies many chromatin sites with GR; when activated by PPAR-α agonists, additional PPAR-α is recruited to GR-adjacent sites and presumably facilitates GR-dependent BFU-E self-renewal. Our discovery of the role of PPAR-α agonists in stimulating self-renewal of early erythroid progenitor cells suggests that the clinically tested PPAR-α agonists we used may improve the efficacy of corticosteroids in treating Epo-resistant anaemias.

Original languageEnglish (US)
Pages (from-to)474-477
Number of pages4
JournalNature
Volume522
Issue number7557
DOIs
StatePublished - Jun 25 2015

Fingerprint

Peroxisome Proliferator-Activated Receptors
Glucocorticoid Receptors
Erythroid Precursor Cells
Erythropoietin
Anemia
Erythroid Cells
Adrenal Cortex Hormones
Diamond-Blackfan Anemia
Erythrocytes
Bone Marrow Diseases
Fenofibrate
Erythropoiesis
Reticulocytes
Hemolytic Anemia
Hemolysis
Glucocorticoids
Chromatin
Sepsis
Cell Culture Techniques
Liver

ASJC Scopus subject areas

  • General

Cite this

Lee, H. Y., Gao, X., Barrasa, M. I., Li, H., Elmes, R. R., Peters, L. L., & Lodish, H. F. (2015). PPAR-α and glucocorticoid receptor synergize to promote erythroid progenitor self-renewal. Nature, 522(7557), 474-477. https://doi.org/10.1038/nature14326

PPAR-α and glucocorticoid receptor synergize to promote erythroid progenitor self-renewal. / Lee, Hsiang Ying; Gao, Xiaofei; Barrasa, M. Inmaculada; Li, Hu; Elmes, Russell R.; Peters, Luanne L.; Lodish, Harvey F.

In: Nature, Vol. 522, No. 7557, 25.06.2015, p. 474-477.

Research output: Contribution to journalArticle

Lee, HY, Gao, X, Barrasa, MI, Li, H, Elmes, RR, Peters, LL & Lodish, HF 2015, 'PPAR-α and glucocorticoid receptor synergize to promote erythroid progenitor self-renewal', Nature, vol. 522, no. 7557, pp. 474-477. https://doi.org/10.1038/nature14326
Lee, Hsiang Ying ; Gao, Xiaofei ; Barrasa, M. Inmaculada ; Li, Hu ; Elmes, Russell R. ; Peters, Luanne L. ; Lodish, Harvey F. / PPAR-α and glucocorticoid receptor synergize to promote erythroid progenitor self-renewal. In: Nature. 2015 ; Vol. 522, No. 7557. pp. 474-477.
@article{1d0e031a061242c0a068b70f319b34e2,
title = "PPAR-α and glucocorticoid receptor synergize to promote erythroid progenitor self-renewal",
abstract = "Many acute and chronic anaemias, including haemolysis, sepsis and genetic bone marrow failure diseases such as Diamond-Blackfan anaemia, are not treatable with erythropoietin (Epo), because the colony-forming unit erythroid progenitors (CFU-Es) that respond to Epo are either too few in number or are not sensitive enough to Epo to maintain sufficient red blood cell production. Treatment of these anaemias requires a drug that acts at an earlier stage of red cell formation and enhances the formation of Epo-sensitive CFU-E progenitors. Recently, we showed that glucocorticoids specifically stimulate self-renewal of an early erythroid progenitor, burst-forming unit erythroid (BFU-E), and increase the production of terminally differentiated erythroid cells. Here we show that activation of the peroxisome proliferator-activated receptor α (PPAR-α) by the PPAR-α agonists GW7647 and fenofibrate synergizes with the glucocorticoid receptor (GR) to promote BFU-E self-renewal. Over time these agonists greatly increase production of mature red blood cells in cultures of both mouse fetal liver BFU-Es and mobilized human adult CD34 + peripheral blood progenitors, with a new and effective culture system being used for the human cells that generates normal enucleated reticulocytes. Although Ppara-/- mice show no haematological difference from wild-type mice in both normal and phenylhydrazine (PHZ)-induced stress erythropoiesis, PPAR-α agonists facilitate recovery of wild-type but not Ppara-/- mice from PHZ-induced acute haemolytic anaemia. We also show that PPAR-α alleviates anaemia in a mouse model of chronic anaemia. Finally, both in control and corticosteroid-treated BFU-E cells, PPAR-α co-occupies many chromatin sites with GR; when activated by PPAR-α agonists, additional PPAR-α is recruited to GR-adjacent sites and presumably facilitates GR-dependent BFU-E self-renewal. Our discovery of the role of PPAR-α agonists in stimulating self-renewal of early erythroid progenitor cells suggests that the clinically tested PPAR-α agonists we used may improve the efficacy of corticosteroids in treating Epo-resistant anaemias.",
author = "Lee, {Hsiang Ying} and Xiaofei Gao and Barrasa, {M. Inmaculada} and Hu Li and Elmes, {Russell R.} and Peters, {Luanne L.} and Lodish, {Harvey F.}",
year = "2015",
month = "6",
day = "25",
doi = "10.1038/nature14326",
language = "English (US)",
volume = "522",
pages = "474--477",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Publishing Group",
number = "7557",

}

TY - JOUR

T1 - PPAR-α and glucocorticoid receptor synergize to promote erythroid progenitor self-renewal

AU - Lee, Hsiang Ying

AU - Gao, Xiaofei

AU - Barrasa, M. Inmaculada

AU - Li, Hu

AU - Elmes, Russell R.

AU - Peters, Luanne L.

AU - Lodish, Harvey F.

PY - 2015/6/25

Y1 - 2015/6/25

N2 - Many acute and chronic anaemias, including haemolysis, sepsis and genetic bone marrow failure diseases such as Diamond-Blackfan anaemia, are not treatable with erythropoietin (Epo), because the colony-forming unit erythroid progenitors (CFU-Es) that respond to Epo are either too few in number or are not sensitive enough to Epo to maintain sufficient red blood cell production. Treatment of these anaemias requires a drug that acts at an earlier stage of red cell formation and enhances the formation of Epo-sensitive CFU-E progenitors. Recently, we showed that glucocorticoids specifically stimulate self-renewal of an early erythroid progenitor, burst-forming unit erythroid (BFU-E), and increase the production of terminally differentiated erythroid cells. Here we show that activation of the peroxisome proliferator-activated receptor α (PPAR-α) by the PPAR-α agonists GW7647 and fenofibrate synergizes with the glucocorticoid receptor (GR) to promote BFU-E self-renewal. Over time these agonists greatly increase production of mature red blood cells in cultures of both mouse fetal liver BFU-Es and mobilized human adult CD34 + peripheral blood progenitors, with a new and effective culture system being used for the human cells that generates normal enucleated reticulocytes. Although Ppara-/- mice show no haematological difference from wild-type mice in both normal and phenylhydrazine (PHZ)-induced stress erythropoiesis, PPAR-α agonists facilitate recovery of wild-type but not Ppara-/- mice from PHZ-induced acute haemolytic anaemia. We also show that PPAR-α alleviates anaemia in a mouse model of chronic anaemia. Finally, both in control and corticosteroid-treated BFU-E cells, PPAR-α co-occupies many chromatin sites with GR; when activated by PPAR-α agonists, additional PPAR-α is recruited to GR-adjacent sites and presumably facilitates GR-dependent BFU-E self-renewal. Our discovery of the role of PPAR-α agonists in stimulating self-renewal of early erythroid progenitor cells suggests that the clinically tested PPAR-α agonists we used may improve the efficacy of corticosteroids in treating Epo-resistant anaemias.

AB - Many acute and chronic anaemias, including haemolysis, sepsis and genetic bone marrow failure diseases such as Diamond-Blackfan anaemia, are not treatable with erythropoietin (Epo), because the colony-forming unit erythroid progenitors (CFU-Es) that respond to Epo are either too few in number or are not sensitive enough to Epo to maintain sufficient red blood cell production. Treatment of these anaemias requires a drug that acts at an earlier stage of red cell formation and enhances the formation of Epo-sensitive CFU-E progenitors. Recently, we showed that glucocorticoids specifically stimulate self-renewal of an early erythroid progenitor, burst-forming unit erythroid (BFU-E), and increase the production of terminally differentiated erythroid cells. Here we show that activation of the peroxisome proliferator-activated receptor α (PPAR-α) by the PPAR-α agonists GW7647 and fenofibrate synergizes with the glucocorticoid receptor (GR) to promote BFU-E self-renewal. Over time these agonists greatly increase production of mature red blood cells in cultures of both mouse fetal liver BFU-Es and mobilized human adult CD34 + peripheral blood progenitors, with a new and effective culture system being used for the human cells that generates normal enucleated reticulocytes. Although Ppara-/- mice show no haematological difference from wild-type mice in both normal and phenylhydrazine (PHZ)-induced stress erythropoiesis, PPAR-α agonists facilitate recovery of wild-type but not Ppara-/- mice from PHZ-induced acute haemolytic anaemia. We also show that PPAR-α alleviates anaemia in a mouse model of chronic anaemia. Finally, both in control and corticosteroid-treated BFU-E cells, PPAR-α co-occupies many chromatin sites with GR; when activated by PPAR-α agonists, additional PPAR-α is recruited to GR-adjacent sites and presumably facilitates GR-dependent BFU-E self-renewal. Our discovery of the role of PPAR-α agonists in stimulating self-renewal of early erythroid progenitor cells suggests that the clinically tested PPAR-α agonists we used may improve the efficacy of corticosteroids in treating Epo-resistant anaemias.

UR - http://www.scopus.com/inward/record.url?scp=84933074090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84933074090&partnerID=8YFLogxK

U2 - 10.1038/nature14326

DO - 10.1038/nature14326

M3 - Article

C2 - 25970251

AN - SCOPUS:84933074090

VL - 522

SP - 474

EP - 477

JO - Nature

JF - Nature

SN - 0028-0836

IS - 7557

ER -